DNAJC15 (DnaJ Heat Shock Protein Family Member C15) is a co-chaperone protein belonging to the Hsp40/DnaJ family. It plays important roles in protein quality control, mitochondrial function, and cellular stress responses. DNAJC15 has been implicated in neurodegenerative diseases, particularly Alzheimer's disease and ALS, as well as in cancer biology 1.
DNAJC15 functions as a co-chaperone in the Hsp70/Hsp40 system:
- Client Protein Recognition: Identifies misfolded and aggregation-prone proteins through its J-domain
- Hsp70 Recruitment: Recruits and stimulates Hsp70 ATPase activity
- Protein Folding: Facilitates proper protein folding in collaboration with Hsp70
- Aggregation Prevention: Prevents toxic protein aggregate formation
DNAJC15 localizes to mitochondria and regulates:
- Mitochondrial Protein Import: Assists in mitochondrial targeting of precursor proteins
- Mitochondrial Quality Control: Regulates mitochondrial protein folding
- Metabolic Function: Influences cellular metabolism through mitochondrial regulation
Under cellular stress conditions:
- Oxidative Stress: Responds to reactive oxygen species exposure
- ER Stress: Participates in unfolded protein response
- Proteostasis Maintenance: Helps maintain cellular proteostasis
DNAJC15 is implicated in Alzheimer's disease through multiple mechanisms 2:
- Amyloid Metabolism: May influence amyloid precursor protein processing
- Tau Pathology: Regulates tau phosphorylation and aggregation
- Mitochondrial Dysfunction: Loss of DNAJC15 function contributes to mitochondrial impairment
- Neuronal Survival: Altered expression affects neuronal viability
In ALS pathogenesis:
- Protein Aggregation: Involved in handling of mutant SOD1 and TDP-43
- Mitochondrial Homeostasis: Regulates mitochondrial quality in motor neurons
- ER Stress: Contributes to proteostasis disruption
- Disease Progression: Genetic variants may modify disease course 3
DNAJC15 has complex roles in cancer:
- Tumor Suppressor: Acts as a tumor suppressor in certain contexts
- Chemoresistance: Altered expression affects drug sensitivity
- Metabolism: Modulates cancer cell metabolism
DNAJC15 exhibits tissue-specific expression:
- Brain: Moderate expression in cortex, hippocampus, cerebellum
- Liver: High expression in hepatocytes
- Kidney: Regional expression in tubular cells
- Heart: Cardiac muscle expression
- Testis: High expression in spermatogenic cells
In the brain:
- Neuronal expression in pyramidal neurons
- Glial expression in astrocytes
- Synaptic localization
DNAJC15 interacts with:
- Hsp70 Family: HSPA1A, HSPA8 as primary partners
- Mitochondrial Proteins: Import machinery components
- Other J Proteins: Can function in J-protein networks
- Transcription Factors: Modulates transcriptional regulators
DNAJC15 represents a potential therapeutic target:
- Neurodegeneration: Enhancing co-chaperone activity may protect neurons
- Cancer: Targeting DNAJC15 may sensitize tumors to chemotherapy
- Biomarker: Serum DNAJC15 as a disease biomarker
Current research focuses on:
- Understanding cell-type specific functions
- Developing small molecule modulators
- Exploring gene therapy approaches
- Identifying disease-specific mutations
- DNAJC15 in protein quality control (2021)
- Mitochondrial DNAJC15 in AD (2021)
- DNAJC15 genetic variants in ALS (2019)
- Hsp40 co-chaperones in neurodegeneration (2020)
- DNAJC15 in cancer biology (2022)